OncoXome was founded in January 2021, incorporated as a Delware C corp, and currently located in Los Angeles, California. We are an oncology startup whose objective is to bring to patients with advanced cancer an innovative multitarget therapeutic approach hacking cell communication and using gene editing to overcome cancer resistance.